ValueSet for Neuroendocrine Cancer Type Published

Details

This article references the reference information for a FHIR ValueSet named 'canshare-mo-neuroendocrine-cancer-type'. It was created to standardize the types of primary neuroendocrine solid cancers assessed and treated by medical oncology services in New Zealand (NZ). Technically, this ValueSet is defined by referencing standard systems like SNOMED CT, combining specific condition codes (e.g., 371966005 Adrenal medulla primary). This enables consistent data exchange among healthcare institutions, improving interoperability in diagnosis and treatment records. A FHIR ValueSet functions as a logical grouping of multiple standardized concepts (Concepts), forming a 'set' with specific clinical meaning. This case serves as an example of developing structured data to meet region-specific medical needs, which could provide guidelines for standardizing the handling of disease classification codes in Japanese electronic health records and dispensing systems. The use of standardized ValueSets, as shown here, allows establishing a common understanding—what 'condition' is being discussed—even between different information systems.